Eye drop trial aims to halt diabetic vision damage
NCT ID NCT06599684
Summary
This study tested whether a new eye drop called INV-102 could help control diabetic retinopathy, a common cause of vision loss. It involved 19 adults with diabetes who had swelling in the back of the eye. Researchers gave participants the eye drops for 8-12 weeks to see if it reduced the severity of their eye disease and swelling.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC RETINOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MedTrials, Inc.
Dallas, Texas, 75204, United States
Conditions
Explore the condition pages connected to this study.